Koo et al. [9] found that GDF-15 levels were considerably greater in NASH patients than in control participants and NAFLD patients in a biopsy-confirmed NAFLD cohort. The gene discussed is GDF15; the disease is metabolic dysfunction-associated steatotic liver disease.